WKN DE: A3DZG2 / ISIN: US14216R1014

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV		Knock-Outs
Historisch			Analysen

Kurse + Charts + Realtime
Kurs + Chart
Chart (groß)
Times + Sales
Chartvergleich
Börsenplätze
Realtime Push
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Aktion
Portfolio
Watchlist

Carisma Therapeutics Times and Sales (STU)

Zeit	Kurs	Umsatz (Stk)	Umsatz grafisch
Times and Sales Zur Zeit stehen keine Daten zur Verfügung

Kursrückgang	Kursanstieg	keine Kursänderung
(Balkenlänge beschreibt das Umsatzvolumen)

Analysen zu Carisma Therapeutics

Weitere Meldungen

02:30		Could Buying USA Rare Earth Stock Today Set You Up for Life?
02:05		IT Spending Will Exceed $6 Trillion for the First Time in 2026 Thanks to Artificial Intelligence (AI). Here's How to Invest.
01:36		For Trump, a Promised Economic Boom Collides With the Costs of War
01:28		Prediction: This Artificial Intelligence (AI) Chip Stock Will Become the Next Nvidia by 2030
01:15		The Best Stocks to Invest $1,000 In Right Now -- and One of Them Is Nvidia
00:47		Where Could BYD Be in 3 Years? -- The Bear Case
00:30		Why This Greg Abel "No Bold Moves" Backlash Could Be a Gift for Patient Investors
00:15		Billionaire Bill Ackman Has 48% of His Hedge Fund's $14 Billion Stock Portfolio Invested in 3 Outstanding Companies
14.03.26		Billionaire Dan Loeb Sold Shares of AI Leaders Including Amazon, Microsoft, and Meta and Added to His Position in This AI Player That's Soared 453,000% Since Its IPO
14.03.26		1 Unbelievable Stat That Makes Me Bullish on AI Stocks
14.03.26		FedEx Just Took UPS's Spot as the Biggest U.S. Parcel Firm. Which Stock is a Smarter Buy in 2026?
14.03.26		QuantumScape Stock Is Down 63%. Is It Finally Time to Buy?
14.03.26		Netflix Stock Has Soared Since It Walked Away From Warner Bros. Time to Buy?
14.03.26		Prediction: SoundHound AI Could Surge As Voice Commerce Takes Off
14.03.26		The Walmart Metric to Watch in 2026
14.03.26		This Passed-Over Stock, 55% Off of Its All-Time High, Is Crushing the Market This Year. Is It the Ultimate Contrarian Stock to Buy Now?
14.03.26		Trump Opens New Trade Probes To Support Tariffs On Subsidies And Forced Labor
14.03.26		Trump Warns Iran: 'One Way or The Other, We Will Soon Get the Hormuz Strait OPEN, SAFE, and FREE'
14.03.26		WADA Rejects Report Claiming Possible Ban On Trump, US Officials From LA Olympics
14.03.26		SPXL vs. SSO: Which Leveraged S&P 500 ETF Is Right for You?
14.03.26		Is Veeva Systems a Multimillionaire-Maker Stock?
14.03.26		Is Dave Stock a Buy or Sell After a Director Dumped 30,000 Shares Worth $6.4 Million?
14.03.26		Instagram accounts trivialize the Holocaust
14.03.26		Satya Nadella Says "All Software Is Being Rewritten." Here's 1 of the Best Artificial Intelligence (AI) Stocks to Own for 2026.
14.03.26		You Won't Believe How Much Money Berkshire Hathaway Gets From Moody's Dividends
14.03.26		Today's Wordle Hints, Answer and Help for March 15, #1730
14.03.26		BuzzFeed Flags Liquidity Doubts but CEO Pushes AI Future: 'Software Is the New Content'
14.03.26		The Artificial Intelligence (AI) Stock That Refuses to Slow Down, and It's Not Nvidia
14.03.26		3 Reasons to Buy Pinterest Stock Like There's No Tomorrow
14.03.26		Nvidia Just Gave Incredible News to Nebius Stock Investors
14.03.26		If You're Behind on Retirement Savings at 50, Here's a Strategy That Could Help You Catch Up
14.03.26		Top 10: Die besten Saugroboter im Test - Roborock vor Ecovacs, Eufy & Dyson
14.03.26		Is Globalstar Stock a Buy After Greenhouse Funds Added Over 75,000 Shares to Its Position?
14.03.26		3 Reasons to Sell Beyond Meat Stock Before It's Too Late
14.03.26		Steve Jobs Was No Straight A Student, But Having The Perfect Grades Isn't The Only Path To Build A $3.76 Trillion Company Like Apple
14.03.26		BYD Just Announced 5-Minute EV Charging. Should Tesla Investors Be Concerned?
14.03.26		Meta Platforms Stock Dips on AI Model Worries. Time to Buy?
14.03.26		Before 'One Battle After Another,' Leonardo DiCaprio Was a Delightful Mess in This Netflix Satire
14.03.26		Should You Forget Palantir and Buy These 2 Tech Stocks Instead?
14.03.26		Interne Chats: Live-Nation-Mitarbeiter finden Kunden „so dumm“
14.03.26		Should You Buy Plug Power Stock While It's Below $3?
14.03.26		Why There Could Be More to Come After Bloom Energy Stock Soared This Week?
14.03.26		Better EV Stock: Rivian vs. Tesla
14.03.26		The Bull Case and Bear Case for CoreWeave Stock Right Now
14.03.26		Alphabet vs. American Express: Which Warren Buffett Stock Is a Better Buy?
14.03.26		Biomea Fusion Reports Positive Phase II Data For Diabetes Drug Icovamenib
14.03.26		Why CoreWeave Stock Surged Higher This Week
14.03.26		Palmer Luckey Turned His Side Hustle That Began Life As A Teen-Run Online Forum Into A $1 Billion Valuation Opportunity: Here's How He Did It
14.03.26		Ethnic Serbs fear impact of Kosovo's Law on Foreigners
14.03.26		Germany's Greens: More than leftist, woke ecologists?

1 | Weiter

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Weitere Aktien: The Food Revolution Group True Corporation China Silver Technology Holdings Ayfie Group AS Registered Shs Itcons E-Solutions

Kontakt - Impressum - Werbung - Barrierefreiheit

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2026 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 79% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	15.03.2026 03:20
Kaufwert:	EUR
	Hinzufügen Speichern

Carisma Therapeutics Aktie

WKN DE: A3DZG2 / ISIN: US14216R1014

Carisma Therapeutics Times and Sales (STU)

Times and Sales

Analysen zu Carisma Therapeutics

Weitere Meldungen